top of page

Anaphylactic Shock - #MEDSHED

Welcome to the #MEDSHED! Needing a brief, concise review of clinical pharmacotherapy and disease management? Direct links of reference to content discussed? Look no further than the #MEDSHED series based on infographics and carousel presentations!

 


 

đŸŒ Anaphylactic Shock Pharmacologic Agents - #MEDSHED



đŸ„œYou’d actually be surprised how many people die each year from bee stings and peanuts. Anaphylactic shock is derived from mast cells, basophils, and histamanergic-mediated acute onset of hypersensitivity and inflammation.



💣This will progress to profuse vasodilation, decreased venous return/CO, and eventual shock. Around 90% of patients will present with angioedema, which is inflammation of the throat, tongue, and lips. If left untreated, patients can rapidly progress to acute cardiopulmonary arrest.



🐍Epinephrine agonizes alpha and beta receptors, leading to bronchodilation, increased inotropy, and vasoconstriction.



đŸČGive 0.3 to 0.5 mg IM q 5 min up to three doses, then transition to IV epinephrine for refractory shock. Thigh is preferable given the vasculature provides a faster onset compared to the deltoid. Consider glucagon when patients are on beta blockers. Glucagon is indicated given it will promote inotropy/chronotropy via increased cAMP and bybassing adrenergic receptors.



đŸ€œEverything we give is considered to be symptomatic and only given after epinephrine has been given (when indicated). Diphehydramine (H1-antihistamine) addresses symptomatic control of urticuria. Famotidine (H2 receptor antagonist) has minimal acute effect given H2 receptors are primarily in gut. Steroids have limited acute benefit since their onset is 4 to 6 hours their biphasics prevention is questionable.



📋 I'd really appreciate the support sharing my page, checking on my prior content (you can scroll for DAYS), drop by my pharmwyze.com/shop, and keep tuning in.



Social Medias: linktr.ee/pharmwyze



5 views0 comments

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page